Mutations in MYLK cause a vascular disease that is different both from that in Marfan syndrome and from that associated with mutations that disrupt TGF-β signaling pathways (mutations in TGFβR1, TGFβR2, SMAD3, TGFβ2, TGFβ3). Here, TGFBR2 is linked to Marfan syndrome.